Michael Geraghty - 06 Jul 2022 Form 4 Insider Report for Apyx Medical Corp (APYX)

Reporting owner
Role
Director
Signature
/s/ Michael Geraghty
Issuer context
Issuer symbol
APYX
Transaction snapshot
Transactions as of
06 Jul 2022
Net transaction value
+$10,160
SEC evidence
Form type
4
Filing time
11 Jul 2022, 10:22:31 UTC
Previous filing
19 May 2022
Next filing
17 Aug 2022
SEC filing
View on sec.gov

Key filing fact

Michael Geraghty filed Form 4 for Apyx Medical Corp (APYX) on 11 Jul 2022.

Key facts

  • This page summarizes Michael Geraghty's Form 4 filing for Apyx Medical Corp (APYX).
  • 2 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 11 Jul 2022, 10:22.

Change

  • Previous filing in this sequence was filed on 19 May 2022.
  • Current net transaction value: +$10,160.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

APYX transaction

Common Stock

Options Exercise

Transaction value
$10,160
Shares
+4,000
Change %
+30%
Price
$2.54
Shares after
17,500
Date
06 Jul 2022
Ownership
Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

APYX transaction Derivative

Stock Option (Option to Buy)

Options Exercise

Transaction value
$0
Shares
-4,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
06 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,000
Exercise price
$2.54
Footnotes
F1
* indicates a reported price that failed the local validity check.

Explanation of Responses:

Id Content
F1 Reporting Person was granted a stock option that vested and became exercisable over 3 years at a rate of 33.33% of the option on the anniversary date of each succeeding year.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .